Developer
SUPERita Games: Revenue & Sales Estimates
Est. catalog lifetime net (USD): $14KRevenue estimates for the 9 Steam games developed by SUPERita, ranked by estimated net revenue. Available estimated lifetime net (USD): $14K.
Catalog Est. Lifetime Net (USD)
$14K
Estimates for 3 of 9 tracked games
Tracked games
9
Top Earner
Whale Flesh
$9K
Coverage: 9 tracked titles; 3 with net estimates; 6 without. 0 have dedicated profiles. Missing estimates are excluded from the aggregate, not treated as known zero revenue.
Role: Developer. These are lifetime estimates for games credited to SUPERita; they are not company earnings, profit, or contractual receipts. Credits may omit co-development or historical publishing arrangements. Developer and publisher identities are not merged by matching names.
Recorded release dates: 2022-12-28–2025-08-25 (may include announced dates).
Largest title accounts for 64.2% of available estimated net revenue. Coverage gaps can change this share.
Showing 1–9 of the top 9 displayed entries, from 9 tracked titles. Figures include only available estimates. Search the full catalog .
Rows 1–9 · Page 1 of 1
| # | Game | Est. lifetime net (USD) | Positive reviews (raw) | Release |
|---|---|---|---|---|
| 1 | Whale Flesh | $9K | 72%Positive (64) | Feb 10, 2025 |
| 2 | A game about cards | $3.1K | 80%Positive (20) | Aug 25, 2025 |
| 3 | Thunder Ronin | $1.9K | 68%Mixed (31) | Jun 17, 2024 |
| 4 | Grim Knight | — | 88%Positive (16) | Dec 28, 2022 |
| 5 | King Krieg | — | 70%Positive (30) | Aug 31, 2023 |
| 6 | Mars vs. Robots | — | 92%Positive (12) | Nov 15, 2024 |
| 7 | Wyrmfall | — | (0) | — |
| 8 | Sweepcremental | — | (0) | — |
| 9 | IncreKnight | — | (0) | — |
Get real-time dashboards, historical trends, and AI-powered analysis
Explore on PlayRev(opens in new tab)Revenue and sales estimates are based on the Boxleiter method using publicly available data including Steam review counts, pricing history, and statistical modeling. Actual revenue may differ significantly. These figures are provided for informational purposes only and should not be used for financial decisions. Read the full methodology.